News
Oilfield services firm Baker Hughes said on Tuesday it would buy Chart Industries in a $13.6 billion all-cash deal, including ...
The sudden and overwhelming demand for GLP-1 agonists, like Ozempic and Wegovy, has placed immense pressure on pharmaceutical supply chains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback